January 9, 2012
SAN DIEGO -- Gen-Probe's (NASDAQ: GPRO) multiple new product launches are off to a good start and should help drive accelerating, double-digit revenue growth in 2012, according to Carl Hull, Gen-Probe's chairman and CEO, who will discuss the Company's 2011 accomplishments and future strategies with investors at JP Morgan's 30th annual healthcare conference in San [...]
January 9, 2012
HILDEN and BERLIN, Germany - QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime. Financial terms were not disclosed. Approximately one-third [...]
Expanded Range of Tissue Culture Treated Microplates
January 9, 2012
Porvair Sciences has expanded its range of tissue culture treated clear bottomed microplates. Now available in 6-, 12-, 24- and 96-well formats - the bottom surface of Porvair tissue culture treated microplates is treated to enhance cellular attachment and growth in uniform layers. These high quality, clear bottomed plates allow cells grown on their bottom [...]
January 9, 2012
OMAHA, Neb. & THE WOODLANDS, Texas-- Transgenomic, Inc. (OTCBB: TBIO) and Power3 Medical Products, Inc. (OTCBB: PWRM) today announced that, following mediation through the offices of the United States District Court for the District of Nebraska, all pre-existing litigations and disputes between the companies have been resolved and terminated, effective immediately. The dispute related to [...]
Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
January 8, 2012
AN DIEGO -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced highlights of the Company's 2011 performance and accomplishments, as well as preliminary activities and goals for the first part of 2012. Initial 2011 Performance Results Total revenue growth of approximately 23 percent year-over-year for 2011 (unaudited). Over [...]
Thermo Fisher Scientific Makes it Easy to Optimize Any Assay
January 8, 2012
ROCHESTER, N.Y. – Thermo Fisher Scientific Inc., the world leader in serving science, offers the new Thermo Scientific immunoassay plate guide as a keyword rich, fully searchable online resource, as well as in a tablet PC format. As a result of the keyword driven content, you can simply type a phrase into the search box [...]
Real Time Genomics Enters Agribusiness Sector with RTG Investigator™
January 6, 2012
San Francisco, CA - Real Time Genomics, Inc., today announced that the Livestock Improvement Corporation (LIC) of New Zealand has signed a multi-year agreement to license RTG Investigator sequence analysis software for trait discovery in bovine genomes. Through an Early Access Program (EAP) relationship with LIC, Real Time Genomics extended its Bayesian variant analysis software [...]
Roka Bioscience Secures $47.5 Million in Series D Financing
January 6, 2012
WARREN, N.J. -- Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka's Board of [...]
HORIBA consolidates its U.S. operations
January 6, 2012
HORIBA, Ltd. announced the restructuring of the U.S. subsidiaries, including the merger of 4 U.S. subsidiaries to HORIBA International Corporation’s affiliate, HORIBA Instruments Incorporated which is expected to aggregate the U.S. business structure. This facilitates the business performance and provides further competitive edge in sales in North America which has the largest analytical and measurement [...]
Pacific Biosciences Names Michael W. Hunkapiller Chief Executive Officer
January 6, 2012
MENLO PARK, Calif. – Pacific Biosciences of California, Inc. (NASDAQ:PACB), provider of Single Molecule Real Time (SMRT®) sequencing products, today announced the appointment of Michael W. Hunkapiller, Ph.D., as President and Chief Executive Officer effective immediately. He succeeds Hugh Martin, who will remain on the Board of Directors through the company’s next annual meeting of [...]
